Portfolio Holdings Detail for ISIN IE00BDZVHG35
Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /var/www/liquidata/show_ticker_holding_ETFs.php on line 67
Stock Name / Fund iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Issuer Blackrock

ETF Ticker BTEE(USD) LSE
ETF Ticker BTEE.L(GBP) LSE

Holdings detail for EOLS

Stock Name	Evolus Inc
Ticker	EOLS(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US30052C1071
LEI	549300VYQRYBQOT8V419

Show aggregate EOLS holdings

News associated with EOLS

BTIG Research Reiterates Buy Rating for Evolus (NASDAQ:EOLS): Evolus (NASDAQ:EOLS – Get Free Report)‘s stock had its “buy” rating reaffirmed by equities research analysts at BTIG Research in a research note issued to investors on Monday,Benzinga reports. They currently have a $18.00 target price on the stock. BTIG Research’s price objective would indicate a potential upside of 143.57% from the company’s current price. […] - 2025-09-10 02:40:50
Evolus (NASDAQ:EOLS) Cut to “Sell” at Wall Street Zen: Wall Street Zen lowered shares of Evolus (NASDAQ:EOLS – Free Report) from a hold rating to a sell rating in a research note published on Saturday morning. A number of other brokerages have also recently issued reports on EOLS. HC Wainwright reduced their price objective on Evolus from $27.00 to $20.00 and set a “buy” […] - 2025-08-12 03:11:00
Evolus (NASDAQ:EOLS) Hits New 1-Year Low Following Analyst Downgrade: Shares of Evolus, Inc. (NASDAQ:EOLS – Get Free Report) hit a new 52-week low during mid-day trading on Thursday after BTIG Research lowered their price target on the stock from $21.00 to $18.00. BTIG Research currently has a buy rating on the stock. Evolus traded as low as $5.85 and last traded at $6.37, with […] - 2025-08-07 02:24:59
Y Intercept Hong Kong Ltd Invests $449,000 in Evolus, Inc. (NASDAQ:EOLS): Y Intercept Hong Kong Ltd purchased a new position in Evolus, Inc. (NASDAQ:EOLS – Free Report) in the 1st quarter, HoldingsChannel reports. The institutional investor purchased 37,361 shares of the company’s stock, valued at approximately $449,000. Other large investors have also recently made changes to their positions in the company. KLP Kapitalforvaltning AS bought a […] - 2025-07-29 05:16:59
Evolus (NASDAQ:EOLS) Shares Down 5.5% on Insider Selling: Evolus, Inc. (NASDAQ:EOLS – Get Free Report) shares dropped 5.5% on Tuesday following insider selling activity. The company traded as low as $9.31 and last traded at $9.42. Approximately 110,433 shares traded hands during trading, a decline of 88% from the average daily volume of 938,410 shares. The stock had previously closed at $9.96. Specifically, […] - 2025-06-18 02:10:53
Evolus (NASDAQ:EOLS) Shares Gap Up After Insider Buying Activity: Evolus, Inc. (NASDAQ:EOLS – Get Free Report) shares gapped up before the market opened on Wednesday following insider buying activity. The stock had previously closed at $9.87, but opened at $10.17. Evolus shares last traded at $10.38, with a volume of 256,876 shares. Specifically, Director Albert G. White III bought 20,000 shares of the company’s […] - 2025-06-12 02:15:00
Man Group plc Purchases Shares of 10,931 Evolus, Inc. (NASDAQ:EOLS): Man Group plc purchased a new stake in Evolus, Inc. (NASDAQ:EOLS – Free Report) during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm purchased 10,931 shares of the company’s stock, valued at approximately $121,000. A number of other hedge funds also recently bought and sold shares […] - 2025-05-29 05:40:57
Nuveen Asset Management LLC Has $8.50 Million Stock Position in Evolus, Inc. (NASDAQ:EOLS): Nuveen Asset Management LLC lowered its stake in shares of Evolus, Inc. (NASDAQ:EOLS – Free Report) by 14.2% during the 4th quarter, Holdings Channel.com reports. The firm owned 769,576 shares of the company’s stock after selling 127,530 shares during the quarter. Nuveen Asset Management LLC’s holdings in Evolus were worth $8,496,000 as of its most […] - 2025-05-29 04:56:56
BNP Paribas Financial Markets Has $400,000 Position in Evolus, Inc. (NASDAQ:EOLS): BNP Paribas Financial Markets cut its stake in shares of Evolus, Inc. (NASDAQ:EOLS – Free Report) by 42.3% during the 4th quarter, Holdings Channel reports. The fund owned 36,213 shares of the company’s stock after selling 26,535 shares during the period. BNP Paribas Financial Markets’ holdings in Evolus were worth $400,000 as of its most […] - 2025-05-26 04:24:47
Price T Rowe Associates Inc. MD Buys 6,332 Shares of Evolus, Inc. (NASDAQ:EOLS): Price T Rowe Associates Inc. MD increased its stake in Evolus, Inc. (NASDAQ:EOLS – Free Report) by 13.7% in the fourth quarter, Holdings Channel.com reports. The institutional investor owned 52,593 shares of the company’s stock after acquiring an additional 6,332 shares during the period. Price T Rowe Associates Inc. MD’s holdings in Evolus were worth […] - 2025-05-13 04:32:48
Schonfeld Strategic Advisors LLC Increases Position in Evolus, Inc. (NASDAQ:EOLS): Schonfeld Strategic Advisors LLC lifted its position in shares of Evolus, Inc. (NASDAQ:EOLS – Free Report) by 62.6% during the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 34,700 shares of the company’s stock after buying an additional 13,363 shares during the period. Schonfeld Strategic Advisors LLC’s holdings in […] - 2025-05-12 05:42:54
Evolus, Inc. (NASDAQ:EOLS) Shares Sold by Invesco Ltd.: Invesco Ltd. reduced its position in Evolus, Inc. (NASDAQ:EOLS – Free Report) by 81.9% in the 4th quarter, HoldingsChannel.com reports. The fund owned 18,326 shares of the company’s stock after selling 83,072 shares during the quarter. Invesco Ltd.’s holdings in Evolus were worth $202,000 at the end of the most recent quarter. Other institutional investors […] - 2025-05-05 04:26:46
Thursday's ETF Movers: IHE, IHF: In trading on Thursday, the iShares U.S. Pharmaceuticals ETF is outperforming other ETFs, up about 4.6% on the day. Components of that ETF showing particular strength include shares of Eli Lilly, up about 16.3% and shares of Evolus, up about 5.4% on the day. And underperformin - 2025-04-17 13:05:12
ExodusPoint Capital Management LP Purchases New Position in Evolus, Inc. (NASDAQ:EOLS): ExodusPoint Capital Management LP acquired a new position in shares of Evolus, Inc. (NASDAQ:EOLS – Free Report) during the 4th quarter, Holdings Channel reports. The fund acquired 13,525 shares of the company’s stock, valued at approximately $149,000. A number of other hedge funds and other institutional investors have also added to or reduced their stakes […] - 2025-04-15 04:38:57
KLP Kapitalforvaltning AS Invests $106,000 in Evolus, Inc. (NASDAQ:EOLS): KLP Kapitalforvaltning AS bought a new position in shares of Evolus, Inc. (NASDAQ:EOLS – Free Report) during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor bought 9,600 shares of the company’s stock, valued at approximately $106,000. Several other large investors have also recently added to or reduced their […] - 2025-04-11 05:14:55
Evolus, Inc. (NASDAQ:EOLS) Position Boosted by Intech Investment Management LLC: Intech Investment Management LLC raised its holdings in shares of Evolus, Inc. (NASDAQ:EOLS – Free Report) by 32.8% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 18,674 shares of the company’s stock after acquiring an additional 4,613 shares during the period. […] - 2025-03-27 06:29:02
HC Wainwright Reaffirms “Buy” Rating for Evolus (NASDAQ:EOLS): Evolus (NASDAQ:EOLS – Get Free Report)‘s stock had its “buy” rating reissued by investment analysts at HC Wainwright in a research note issued to investors on Wednesday,Benzinga reports. They currently have a $27.00 price objective on the stock. HC Wainwright’s price target would suggest a potential upside of 100.00% from the stock’s current price. Several […] - 2025-03-07 04:50:44
China Universal Asset Management Co. Ltd. Acquires 1,291 Shares of Evolus, Inc. (NASDAQ:EOLS): China Universal Asset Management Co. Ltd. grew its holdings in Evolus, Inc. (NASDAQ:EOLS – Free Report) by 10.6% in the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 13,426 shares of the company’s stock after acquiring an additional 1,291 shares during the period. China Universal Asset Management Co. Ltd.’s holdings in Evolus were worth $148,000 […] - 2025-02-04 06:53:02

iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) EOLS holdings

Date	Number of EOLS Shares Held	Base Market Value of EOLS Shares	Local Market Value of EOLS Shares	Change in EOLS Shares Held	Change in EOLS Base Value	Current Price per EOLS Share Held	Previous Price per EOLS Share Held
2025-12-03 (Wednesday)	48,840	USD 329,670	USD 329,670	0	USD 11,233	USD 6.75	USD 6.52
2025-12-02 (Tuesday)	48,840	USD 318,437	USD 318,437	1,785	USD -2,478	USD 6.52	USD 6.82
2025-12-01 (Monday)	47,055	USD 320,915	USD 320,915	0	USD -15,999	USD 6.82	USD 7.16
2025-11-28 (Friday)	47,055	USD 336,914	USD 336,914	119	USD 6,485	USD 7.16	USD 7.03999
2025-11-27 (Thursday)	46,936	USD 330,429	USD 330,429	0	USD 0	USD 7.03999	USD 7.03999
2025-11-26 (Wednesday)	46,936	USD 330,429	USD 330,429	357	USD 5,308	USD 7.03999	USD 6.97999
2025-11-25 (Tuesday)	46,579	USD 325,121	USD 325,121	595	USD 15,189	USD 6.97999	USD 6.74
2025-11-24 (Monday)	45,984	USD 309,932	USD 309,932	119	USD -4,243	USD 6.74	USD 6.84999
2025-11-21 (Friday)	45,865	USD 314,175	USD 314,175	0	USD 10,549	USD 6.84999	USD 6.61999
2025-11-20 (Thursday)	45,865	USD 303,626	USD 303,626	-472	USD -10,539	USD 6.61999	USD 6.78
2025-11-19 (Wednesday)	46,337	USD 314,165	USD 314,165	118	USD -10,755	USD 6.78	USD 7.03001
2025-11-18 (Tuesday)	46,219	USD 324,920	USD 324,920	708	USD 8,619	USD 7.03001	USD 6.94999
2025-11-17 (Monday)	45,511	USD 316,301	USD 316,301	236	USD -10,585	USD 6.94999	USD 7.22001

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of EOLS by Blackrock for IE00BDZVHG35

Show aggregate share trades of EOLS

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-12-02 BUY 1,785 6.820 6.355 6.402 USD 11,427 10.90
2025-11-28 BUY 119 7.160 6.925 6.949 USD 827 10.94
2025-11-26 BUY 357 7.060 6.930 6.943 USD 2,479 10.98
2025-11-26 BUY 357 7.060 6.930 6.943 USD 2,479 10.98
2025-11-25 BUY 595 7.035 6.800 6.824 USD 4,060 11.00
2025-11-24 BUY 119 6.810 6.610 6.630 USD 789 11.02
2025-11-20 SELL -472 7.000 6.530 6.577 USD -3,104 11.06 Profit of 2,118 on sale
2025-11-19 BUY 118 7.030 6.690 6.724 USD 793 11.09
2025-11-18 BUY 708 7.100 6.820 6.848 USD 4,848 11.11
2025-11-17 BUY 236 7.270 6.930 6.964 USD 1,644 11.13
2025-11-14 BUY 118 7.595 7.180 7.221 USD 852 11.15
2025-11-12 BUY 118 7.425 6.950 6.997 USD 826 11.19
2025-11-10 BUY 117 7.250 6.570 6.638 USD 777 11.23
2025-11-06 BUY 117 7.760 7.105 7.171 USD 839 11.28
2025-11-04 BUY 118 6.690 6.250 6.294 USD 743 11.33
2025-10-30 BUY 590 7.140 6.665 6.712 USD 3,960 11.41
2025-10-29 BUY 236 6.860 7.385 7.333 USD 1,730 11.44
2025-10-22 SELL -468 6.820 6.900 6.892 USD -3,225 11.57 Profit of 2,190 on sale
2025-10-20 BUY 234 6.690 6.710 6.708 USD 1,570 11.63
2025-10-17 BUY 584 6.400 6.410 6.409 USD 3,743 11.66
2025-10-15 BUY 928 6.610 6.620 6.619 USD 6,142 11.69
2025-10-03 BUY 833 6.500 6.550 6.545 USD 5,452 11.75
2025-10-02 BUY 119 6.240 6.350 6.339 USD 754 11.78
2025-09-30 BUY 238 6.140 6.220 6.212 USD 1,478 11.85
2025-09-26 BUY 238 5.990 6.040 6.035 USD 1,436 11.92
2025-09-25 BUY 238 5.980 6.040 6.034 USD 1,436 11.96
2025-09-18 BUY 120 6.420 6.590 6.573 USD 789 12.00
2025-09-17 BUY 360 6.520 6.765 6.740 USD 2,427 12.03
2025-07-17 SELL -232 9.340 9.425 9.417 USD -2,185 12.12 Profit of 627 on sale
2025-07-11 SELL -936 9.480 9.750 9.723 USD -9,101 12.19 Profit of 2,311 on sale
2025-07-02 BUY 6,435 9.210 9.390 9.372 USD 60,309 12.27
2025-06-25 BUY 232 9.100 9.570 9.523 USD 2,209 12.35
2025-06-20 BUY 2,861 9.280 9.430 9.415 USD 26,936 12.42
2025-06-11 BUY 216 10.240 10.620 10.582 USD 2,286 12.56
2025-06-10 BUY 216 9.870 9.920 9.915 USD 2,142 12.58
2025-06-04 SELL -108 9.800 10.032 10.009 USD -1,081 12.66 Profit of 287 on sale
2025-04-23 BUY 107 11.230 11.360 11.347 USD 1,214 13.34
2025-04-10 SELL -856 9.415 9.910 9.860 USD -8,441 13.65 Profit of 3,248 on sale
2025-04-08 SELL -107 9.360 10.710 10.575 USD -1,132 13.74 Profit of 339 on sale
2025-04-07 SELL -106 10.240 10.744 10.694 USD -1,134 13.78 Profit of 327 on sale
2025-04-04 SELL -535 10.690 10.910 10.888 USD -5,825 13.82 Profit of 1,568 on sale
2025-04-01 BUY 440 11.990 12.255 12.229 USD 5,381 13.86
2025-03-31 SELL -321 12.030 12.080 12.075 USD -3,876 13.88 Profit of 580 on sale
2025-03-21 BUY 1,828 13.030 13.300 13.273 USD 24,263 13.99
2025-03-14 SELL -1,632 13.200 13.215 13.214 USD -21,564 14.03 Profit of 1,339 on sale
2025-03-07 SELL -202 13.580 13.810 13.787 USD -2,785 14.11 Profit of 65 on sale
2025-03-04 SELL -101 14.350 14.430 14.422 USD -1,457 14.11 Loss of -31 on sale
2025-02-25 BUY 204 13.960 14.320 14.284 USD 2,914 14.10
2025-02-19 SELL -101 14.880 15.060 15.042 USD -1,519 14.08 Loss of -97 on sale
2025-02-13 BUY 303 15.040 17.120 16.912 USD 5,124 14.02
2025-02-12 BUY 101 14.260 14.280 14.278 USD 1,442 14.01
2025-02-11 BUY 404 13.770 13.830 13.824 USD 5,585 14.02
2024-12-30 SELL -3,098 10.890 11.060 11.043 USD -34,211 14.29 Profit of 10,067 on sale
2024-11-18 SELL -1,635 11.990 12.670 12.602 USD -20,604 15.82 Profit of 5,256 on sale
2024-11-08 SELL -108 13.680 14.350 14.283 USD -1,543 16.21 Profit of 208 on sale
2024-10-21 SELL -109 16.240 16.690 16.645 USD -1,814 0.00 Loss of -1,814 on sale
Market high and low price is on the date.

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-12-02	BUY	1,785	6.820	6.355	6.402	USD 11,427	10.90
2025-11-28	BUY	119	7.160	6.925	6.949	USD 827	10.94
2025-11-26	BUY	357	7.060	6.930	6.943	USD 2,479	10.98
2025-11-26	BUY	357	7.060	6.930	6.943	USD 2,479	10.98
2025-11-25	BUY	595	7.035	6.800	6.824	USD 4,060	11.00
2025-11-24	BUY	119	6.810	6.610	6.630	USD 789	11.02
2025-11-20	SELL	-472	7.000	6.530	6.577	USD -3,104	11.06 Profit of 2,118 on sale
2025-11-19	BUY	118	7.030	6.690	6.724	USD 793	11.09
2025-11-18	BUY	708	7.100	6.820	6.848	USD 4,848	11.11
2025-11-17	BUY	236	7.270	6.930	6.964	USD 1,644	11.13
2025-11-14	BUY	118	7.595	7.180	7.221	USD 852	11.15
2025-11-12	BUY	118	7.425	6.950	6.997	USD 826	11.19
2025-11-10	BUY	117	7.250	6.570	6.638	USD 777	11.23
2025-11-06	BUY	117	7.760	7.105	7.171	USD 839	11.28
2025-11-04	BUY	118	6.690	6.250	6.294	USD 743	11.33
2025-10-30	BUY	590	7.140	6.665	6.712	USD 3,960	11.41
2025-10-29	BUY	236	6.860	7.385	7.333	USD 1,730	11.44
2025-10-22	SELL	-468	6.820	6.900	6.892	USD -3,225	11.57 Profit of 2,190 on sale
2025-10-20	BUY	234	6.690	6.710	6.708	USD 1,570	11.63
2025-10-17	BUY	584	6.400	6.410	6.409	USD 3,743	11.66
2025-10-15	BUY	928	6.610	6.620	6.619	USD 6,142	11.69
2025-10-03	BUY	833	6.500	6.550	6.545	USD 5,452	11.75
2025-10-02	BUY	119	6.240	6.350	6.339	USD 754	11.78
2025-09-30	BUY	238	6.140	6.220	6.212	USD 1,478	11.85
2025-09-26	BUY	238	5.990	6.040	6.035	USD 1,436	11.92
2025-09-25	BUY	238	5.980	6.040	6.034	USD 1,436	11.96
2025-09-18	BUY	120	6.420	6.590	6.573	USD 789	12.00
2025-09-17	BUY	360	6.520	6.765	6.740	USD 2,427	12.03
2025-07-17	SELL	-232	9.340	9.425	9.417	USD -2,185	12.12 Profit of 627 on sale
2025-07-11	SELL	-936	9.480	9.750	9.723	USD -9,101	12.19 Profit of 2,311 on sale
2025-07-02	BUY	6,435	9.210	9.390	9.372	USD 60,309	12.27
2025-06-25	BUY	232	9.100	9.570	9.523	USD 2,209	12.35
2025-06-20	BUY	2,861	9.280	9.430	9.415	USD 26,936	12.42
2025-06-11	BUY	216	10.240	10.620	10.582	USD 2,286	12.56
2025-06-10	BUY	216	9.870	9.920	9.915	USD 2,142	12.58
2025-06-04	SELL	-108	9.800	10.032	10.009	USD -1,081	12.66 Profit of 287 on sale
2025-04-23	BUY	107	11.230	11.360	11.347	USD 1,214	13.34
2025-04-10	SELL	-856	9.415	9.910	9.860	USD -8,441	13.65 Profit of 3,248 on sale
2025-04-08	SELL	-107	9.360	10.710	10.575	USD -1,132	13.74 Profit of 339 on sale
2025-04-07	SELL	-106	10.240	10.744	10.694	USD -1,134	13.78 Profit of 327 on sale
2025-04-04	SELL	-535	10.690	10.910	10.888	USD -5,825	13.82 Profit of 1,568 on sale
2025-04-01	BUY	440	11.990	12.255	12.229	USD 5,381	13.86
2025-03-31	SELL	-321	12.030	12.080	12.075	USD -3,876	13.88 Profit of 580 on sale
2025-03-21	BUY	1,828	13.030	13.300	13.273	USD 24,263	13.99
2025-03-14	SELL	-1,632	13.200	13.215	13.214	USD -21,564	14.03 Profit of 1,339 on sale
2025-03-07	SELL	-202	13.580	13.810	13.787	USD -2,785	14.11 Profit of 65 on sale
2025-03-04	SELL	-101	14.350	14.430	14.422	USD -1,457	14.11 Loss of -31 on sale
2025-02-25	BUY	204	13.960	14.320	14.284	USD 2,914	14.10
2025-02-19	SELL	-101	14.880	15.060	15.042	USD -1,519	14.08 Loss of -97 on sale
2025-02-13	BUY	303	15.040	17.120	16.912	USD 5,124	14.02
2025-02-12	BUY	101	14.260	14.280	14.278	USD 1,442	14.01
2025-02-11	BUY	404	13.770	13.830	13.824	USD 5,585	14.02
2024-12-30	SELL	-3,098	10.890	11.060	11.043	USD -34,211	14.29 Profit of 10,067 on sale
2024-11-18	SELL	-1,635	11.990	12.670	12.602	USD -20,604	15.82 Profit of 5,256 on sale
2024-11-08	SELL	-108	13.680	14.350	14.283	USD -1,543	16.21 Profit of 208 on sale
2024-10-21	SELL	-109	16.240	16.690	16.645	USD -1,814	0.00 Loss of -1,814 on sale

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of EOLS

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	165,857	0	394,935	42.0%
2025-09-18	265,388	0	432,375	61.4%
2025-09-17	289,212	0	362,095	79.9%
2025-09-16	454,460	0	617,227	73.6%
2025-09-15	518,054	0	813,574	63.7%
2025-09-12	94,397	0	266,248	35.5%
2025-09-11	117,730	0	251,107	46.9%
2025-09-10	221,249	0	471,578	46.9%
2025-09-09	189,509	0	530,955	35.7%
2025-09-08	158,906	9	224,453	70.8%
2025-09-05	92,263	0	159,635	57.8%
2025-09-04	156,485	0	238,308	65.7%
2025-09-03	167,270	0	311,111	53.8%
2025-09-02	90,762	0	189,697	47.8%
2025-08-29	85,231	0	148,581	57.4%
2025-08-28	109,409	0	262,043	41.8%
2025-08-27	150,491	0	244,897	61.5%
2025-08-26	200,453	0	382,545	52.4%
2025-08-25	257,609	0	368,338	69.9%
2025-08-22	217,952	0	434,026	50.2%
2025-08-21	202,484	200	305,229	66.3%
2025-08-20	155,480	0	239,966	64.8%
2025-08-19	280,904	0	484,218	58.0%
2025-08-18	222,673	0	382,352	58.2%
2025-08-15	233,445	0	454,202	51.4%
2025-08-14	345,977	900	500,407	69.1%
2025-08-13	350,284	3,451	614,470	57.0%
2025-08-12	297,423	0	824,185	36.1%
2025-08-11	390,482	1,231	1,047,797	37.3%
2025-08-08	680,311	401	1,214,778	56.0%
2025-08-07	631,855	37,268	1,655,307	38.2%
2025-08-06	2,974,051	202,445	6,786,160	43.8%
2025-08-05	475,673	9,400	1,756,067	27.1%
2025-08-04	234,530	262	665,731	35.2%
2025-08-01	284,813	0	802,156	35.5%
2025-07-31	130,057	0	533,437	24.4%
2025-07-30	115,391	0	699,374	16.5%
2025-07-29	201,561	0	403,729	49.9%
2025-07-28	84,295	0	221,071	38.1%
2025-07-25	184,980	0	557,604	33.2%
2025-07-24	250,694	0	807,605	31.0%
2025-07-23	87,797	0	338,471	25.9%
2025-07-22	74,974	181	283,380	26.5%
2025-07-21	112,792	0	285,067	39.6%
2025-07-18	190,856	0	391,153	48.8%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Stock Name / Fund	iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Issuer	Blackrock
ETF Ticker	BTEE(USD) LSE
ETF Ticker	BTEE.L(GBP) LSE